Keith Woods - Oct 16, 2023 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role
Director
Signature
/s/ Adam S. Mostafa, attorney-in-fact
Stock symbol
XFOR
Transactions as of
Oct 16, 2023
Transactions value $
$0
Form type
4
Date filed
10/18/2023, 04:02 PM
Next filing
Dec 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Award $0 +90K $0.00 90K Oct 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock units ("RSUs") grant. The RSUs will vest in three equal annual installments commencing on October 16, 2024, subject to the Reporting Person's continued service as a director through each such date.